Repsol (OTCMKTS:REPYY – Get Rating) was downgraded by investment analysts at Jefferies Financial Group from a “buy” rating to a “hold” rating in a research note issued on Wednesday, The Fly reports.
A number of other equities research analysts also recently weighed in on REPYY. BNP Paribas downgraded Repsol from an “outperform” rating to a “neutral” rating in a report on Tuesday, April 4th. JPMorgan Chase & Co. began coverage on Repsol in a research note on Wednesday, April 19th. They issued an “underweight” rating for the company. Finally, Morgan Stanley cut Repsol from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, April 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, Repsol currently has an average rating of “Hold” and a consensus target price of $16.00.
Repsol Trading Down 0.1 %
Shares of OTCMKTS:REPYY opened at $14.40 on Wednesday. The company has a market capitalization of $19.11 billion, a P/E ratio of 4.82, a P/E/G ratio of 0.45 and a beta of 0.76. Repsol has a 1 year low of $10.79 and a 1 year high of $17.31. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.55 and a quick ratio of 1.12. The business’s 50 day simple moving average is $14.90 and its 200 day simple moving average is $15.28.
About Repsol
Repsol SA is engaged in the exploration and production of crude oil, natural gas, and refined petroleum. It operates through the following business segments: Upstream, Downstream, and Corporation & Others. The Upstream segment engages in exploration and development of crude oil and natural gas reserves.
Featured Articles
- Get a free copy of the StockNews.com research report on Repsol (REPYY)
- It’s Time To Take Another Bite Of Take-Two Interactive
- Zoetis Declares New Dividend, Hinting At Undervaluation
- Good News For Walmart Isn’t So Great For Everybody Else
- Eagle Materials, Answering America’s Building Supply Needs
- Pharma Giants Novartis, Lilly, Merck, and Novo Outperform Market
Receive News & Ratings for Repsol Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Repsol and related companies with MarketBeat.com's FREE daily email newsletter.